EPCAM (also known as Trop1 or CD326) is a type I transmembrane glycoprotein that was originally identified as a novel tumor-specific antigen highly expressed on the surface of many carcinoma cells (Herlyn et al., 1979). This evidence concerns the gene EPCAM and neoplasm.